{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:19:28Z","timestamp":1791285568773,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T00:00:00Z","timestamp":1352851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0048387","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T22:47:43Z","timestamp":1352933263000},"page":"e48387","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":71,"title":["Direct Angiotensin II Type 2 Receptor Stimulation Ameliorates Insulin Resistance in Type 2 Diabetes Mice with PPAR\u03b3 Activation"],"prefix":"10.1371","volume":"7","author":[{"given":"Kousei","family":"Ohshima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Mogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Iwanami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Tsukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Juan","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Ogimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Dahl\u00f6f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike M.","family":"Steckelings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitsuo","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,11,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mce.2008.12.011","article-title":"Angiotensin II and the development of insulin resistance: Implications for diabetes","volume":"302","author":"JA Olivares-Reyes","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"B Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/01.HYP.0000125142.41703.64","article-title":"Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice","volume":"43","author":"T Shiuchi","year":"2004","journal-title":"Hypertension"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/01.hjh.0000163160.60234.15","article-title":"Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy","volume":"23","author":"MH Olsen","year":"2005","journal-title":"J Hypertens"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/01.hjh.0000234122.55895.5b","article-title":"Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: The VALUE trial","volume":"24","author":"SE Kjeldsen","year":"2006","journal-title":"J Hypertens"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"S Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International Union of Pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"M de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2337\/diabetes.54.4.991","article-title":"Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance","volume":"54","author":"L Yvan-Charvet","year":"2005","journal-title":"Diabetes"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/db08-0949","article-title":"Angiotensin II reduces mitochondrial content in skeletal muscle and affects glycemic control","volume":"58","author":"M Mitsuishi","year":"2009","journal-title":"Diabetes"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"14849","DOI":"10.1073\/pnas.1101507108","article-title":"Identification and characterization of a functional mitochondrial angiotensin system","volume":"108","author":"PM Abadir","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1021\/jm0606185","article-title":"Selective angiotensin II AT2 receptor agonists: Arylbenzylimidazole structure-activity relationships","volume":"49","author":"X Wu","year":"2006","journal-title":"J Med Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/1470320309347792","article-title":"Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): Implications for AT2 receptor research and therapeutic potential","volume":"11","author":"T Unger","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ajh.2009.85","article-title":"AT2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice","volume":"22","author":"M Iwai","year":"2009","journal-title":"Am J Hypertens"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/endo.135.5.7956925","article-title":"Differentiation of preadipose cells: Paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II","volume":"135","author":"C Darimont","year":"1994","journal-title":"Endocrinology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/endo.142.1.7883","article-title":"Angiotensin II as a trophic factor of white adipose tissue: Stimulation of adipose cell formation","volume":"142","author":"P Saint-Marc","year":"2001","journal-title":"Endocrinology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1210\/en.2008-1120","article-title":"Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue","volume":"150","author":"L Yvan-Charvet","year":"2009","journal-title":"Endocrinology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cell.2005.11.026","article-title":"The many faces of PPARgamma","volume":"123","author":"M Lehrke","year":"2005","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROACTIVE study (prospective pioglitazone clinical trial in macrovascular events): A randomised controlled trial","volume":"366","author":"JA Dormandy","year":"2005","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: A randomised controlled trial","volume":"368","author":"HC Gerstein","year":"2006","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"SE Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/jama.299.13.1561","article-title":"Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: The periscope randomized controlled trial","volume":"299","author":"SE Nissen","year":"2008","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.CIR.102.15.1834","article-title":"Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells","volume":"102","author":"K Takeda","year":"2000","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1210\/endo.142.7.8272","article-title":"Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells","volume":"142","author":"A Sugawara","year":"2001","journal-title":"Endocrinology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physiolgenomics.00062.2002","article-title":"Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs","volume":"11","author":"DM Tham","year":"2002","journal-title":"Physiol Genomics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"48950","DOI":"10.1074\/jbc.M108722200","article-title":"15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK\/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells","volume":"276","author":"K Takeda","year":"2001","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1471-4159.2005.03275.x","article-title":"Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation","volume":"94","author":"Y Zhao","year":"2005","journal-title":"J Neurochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/01.HYP.25.5.1111","article-title":"A noninvasive computerized tail-cuff system for measuring blood pressure in mice","volume":"25","author":"JH Krege","year":"1995","journal-title":"Hypertension"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/HYPERTENSIONAHA.111.183178","article-title":"Roles of interleukin 17 in angiotensin II type 1 receptor-mediated insulin resistance","volume":"59","author":"K Ohshima","year":"2012","journal-title":"Hypertension"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ajh.2007.50","article-title":"Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models","volume":"21","author":"Y Tomono","year":"2008","journal-title":"Am J Hypertens"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2006.09.071","article-title":"Fetuin-null mice are protected against obesity and insulin resistance associated with aging","volume":"350","author":"ST Mathews","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1210\/endo.142.2.7964","article-title":"Involvement of bradykinin and nitric oxide in leptin-mediated glucose uptake in skeletal muscle","volume":"142","author":"T Shiuchi","year":"2001","journal-title":"Endocrinology"},{"key":"ref32","first-page":"E298","article-title":"Ventromedial hypothalamic stimulation enhances peripheral glucose uptake in anesthetized rats","volume":"261","author":"M Sudo","year":"1991","journal-title":"Am J Physiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-2999(93)90665-5","article-title":"Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112b and PD 123319 in the sodium-depleted rat","volume":"249","author":"D Macari","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.bjp.0705448","article-title":"Angiotensin AT2 receptors: Cardiovascular hope or hype?","volume":"140","author":"RE Widdop","year":"2003","journal-title":"Br J Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1021\/jm049715t","article-title":"Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist","volume":"47","author":"Y Wan","year":"2004","journal-title":"J Med Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/01.hjh.0000388495.66330.63","article-title":"The angiotensin AT2 receptor in left ventricular hypertrophy","volume":"28","author":"UM Steckelings","year":"2010","journal-title":"J Hypertens"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/CIRCULATIONAHA.108.784868","article-title":"Angiotensin IIs type 2 receptor stimulation: A novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?","volume":"118","author":"E Kaschina","year":"2008","journal-title":"Circulation"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"SE Shoelson","year":"2006","journal-title":"J Clin Invest"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"N Ouchi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/sj.cdd.4402127","article-title":"Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin\/TCF4(TCF7l2)-dependent pathway","volume":"14","author":"WP Cawthorn","year":"2007","journal-title":"Cell Death Differ"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance","volume":"271","author":"GS Hotamisligil","year":"1996","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1172\/JCI8538","article-title":"Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency","volume":"105","author":"PD Miles","year":"2000","journal-title":"J Clin Invest"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1210\/me.2002-0036","article-title":"A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity","volume":"16","author":"J Rieusset","year":"2002","journal-title":"Mol Endocrinol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1113\/jphysiol.2006.126193","article-title":"The physiology of a local renin-angiotensin system in the pancreas","volume":"580","author":"PS Leung","year":"2007","journal-title":"J Physiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2337\/diabetes.53.4.989","article-title":"Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat","volume":"53","author":"C Tikellis","year":"2004","journal-title":"Diabetes"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2337\/diabetes.55.02.06.db05-1022","article-title":"Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes","volume":"55","author":"KY Chu","year":"2006","journal-title":"Diabetes"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/HYPERTENSIONAHA.109.148049","article-title":"Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice","volume":"55","author":"BK Cole","year":"2010","journal-title":"Hypertension"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1210\/endo.140.7.6873","article-title":"Tumor necrosis factor-alpha-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic beta cells","volume":"140","author":"LA Stephens","year":"1999","journal-title":"Endocrinology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/sj.ijo.0801657","article-title":"TNFalpha and leptin inhibit basal and glucose-stimulated insulin secretion and gene transcription in the HIT-T15 pancreatic cells","volume":"25","author":"PC Tsiotra","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1463-1326.2010.01299.x","article-title":"The role of peroxisome proliferator-activated receptor gamma in pancreatic beta cell function and survival: Therapeutic implications for the treatment of type 2 diabetes mellitus","volume":"12","author":"D Gupta","year":"2010","journal-title":"Diabetes Obes Metab"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0048387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T22:11:30Z","timestamp":1745187090000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0048387"}},"subtitle":[],"editor":[{"given":"Haiyan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,14]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0048387","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,14]]}}}